J70.2
Acute drug-induced interstitial lung disorders
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Excludes Type 1
- interstitial pneumonia NOS (J84.9)
- lymphoid interstitial pneumonia (J84.2)
Medical Intelligence & Overview
Acute drug-induced interstitial lung disorders represent a group of lung conditions triggered by the adverse effects of certain medications. These disorders involve inflammation and damage to the interstitial tissue of the lungs, which is the supportive framework surrounding the air sacs (alveoli). The resulting impairment can lead to difficulty breathing and decreased oxygen exchange. Recognizing and understanding this condition is vital for early intervention and management. This article provides an overview of causes, symptoms, diagnosis, and treatment options related to acute drug-induced interstitial lung disorders classified under ICD-10 code J70.2.
Causes & Symptoms
Clinical Causes: Certain medications are known to provoke lung reactions, including: - Chemotherapy drugs (e.g., bleomycin, methotrexate) - Antibiotics (e.g., amiodarone, nitrofurantoin) - Anti-inflammatory drugs (e.g., sulfasalazine) - Cardiac medications (e.g., amiodarone) - Other drugs such as amiodarone and certain anti-seizure medications These medications can cause lung inflammation as an adverse reaction, leading to damage of the lung tissue. In some cases, the reaction can occur rapidly after starting the medication, but in others, it might develop after prolonged use.
Key Symptoms: Patients experiencing acute drug-induced interstitial lung disorders may present with: - Sudden onset of shortness of breath - Persistent dry cough - Fever and chills - Fatigue and weakness - Chest discomfort or pain - Rapid breathing (tachypnea) - Cyanosis (a bluish tint to the lips or fingertips) in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical assessment including detailed history-taking, physical examination, and various tests:
Treatment Protocols: Management focuses on removing the offending drug and supporting lung function:
Clinical Advice & FAQs
Billing Guidance
Is J70.2 a billable ICD-10 code?
Yes, J70.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J70.2?
Clinical documentation must specify the nature of Acute drug-induced interstitial lung disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference